A Study to Evaluate the Safety and Efficacy of CBP-201 in Chinese Adult Subjects With Moderate to Severe AD
Clinical trial NCT05905133 · UNKNOWN
Trial details
- NCT number
- NCT05905133
- Sponsor
- Connect Biopharm LLC
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-15
- Primary completion
- 2024-06-30
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.